- Home
- QLGN vs AEMD Comparison
QLGN vs AEMD Comparison
Compare QLGN & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QLGN
- AEMD
- Stock Information
- Founded
- QLGN 1996
- AEMD 1984
- Country
- QLGN United States
- AEMD United States
- Employees
- QLGN N/A
- AEMD N/A
- Industry
- QLGN Biotechnology: Pharmaceutical Preparations
- AEMD Medical/Dental Instruments
- Sector
- QLGN Health Care
- AEMD Health Care
- Exchange
- QLGN Nasdaq
- AEMD Nasdaq
- Market Cap
- QLGN 4.8M
- AEMD 4.1M
- IPO Year
- QLGN N/A
- AEMD N/A
- Fundamental
- Price
- QLGN $5.02
- AEMD $0.72
- Analyst Decision
- QLGN
- AEMD Buy
- Analyst Count
- QLGN 0
- AEMD 2
- Target Price
- QLGN N/A
- AEMD $28.75
- AVG Volume (30 Days)
- QLGN 4.8M
- AEMD 606.1K
- Earning Date
- QLGN 11-13-2025
- AEMD 11-12-2025
- Dividend Yield
- QLGN N/A
- AEMD N/A
- EPS Growth
- QLGN N/A
- AEMD N/A
- EPS
- QLGN N/A
- AEMD N/A
- Revenue
- QLGN N/A
- AEMD N/A
- Revenue This Year
- QLGN N/A
- AEMD N/A
- Revenue Next Year
- QLGN N/A
- AEMD N/A
- P/E Ratio
- QLGN N/A
- AEMD N/A
- Revenue Growth
- QLGN N/A
- AEMD N/A
- 52 Week Low
- QLGN $1.61
- AEMD $0.60
- 52 Week High
- QLGN $10.45
- AEMD $8.44
- Technical
- Relative Strength Index (RSI)
- QLGN 61.57
- AEMD 40.83
- Support Level
- QLGN $4.91
- AEMD $0.71
- Resistance Level
- QLGN $6.16
- AEMD $0.83
- Average True Range (ATR)
- QLGN 1.00
- AEMD 0.05
- MACD
- QLGN 0.06
- AEMD 0.01
- Stochastic Oscillator
- QLGN 43.01
- AEMD 3.72
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.